Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel.
Company profile
Ticker
CMMB
Exchange
Website
CEO
Frank G. Haluska
Employees
Location
SEC CIK
Latest ownership filings